Epigenetic Alterations in Pancreatic Cancer

Authors

  • Jiaqi Shi

Keywords:

KRAS, TP53, SMAD4, and CDKN2A

Abstract

Pancreatic cancer is the fourth leading cause of cancer death and is predicted to be the second leading cause in a decade in the US. Despite more than 50 years of research and therapeutic development, pancreatic cancer still has a median survival rate of 6 months and a 5-year overall survival around 5%. Therefore, there is an urgent need to better understand the mechanism of pancreatic cancer development, as well as to discover new biomarkers for early diagnosis, prognosis, and therapeutic targets.

Downloads

Published

2025-09-08

How to Cite

Jiaqi Shi. (2025). Epigenetic Alterations in Pancreatic Cancer. Pancreas, 1(2), e5-e7. Retrieved from https://openventio.us/index.php/POJ/article/view/1113

Issue

Vol. 1 No. 2 (2015): Volume 1 Issue 2 2015

Section

Articles

License

All content published in Pancreas (POJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.